| pubmed-article:1531148 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1531148 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1531148 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:1531148 | lifeskim:mentions | umls-concept:C0877373 | lld:lifeskim |
| pubmed-article:1531148 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
| pubmed-article:1531148 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1531148 | pubmed:dateCreated | 1992-3-3 | lld:pubmed |
| pubmed-article:1531148 | pubmed:abstractText | Fewer than 20% of patients with nonhematologic malignancies treated with chloroethylnitrosoureas (CENUs) respond, but streptozocin (STZ), which depletes O6-methylguanine-DNA-methyltransferase (MGMT), has been shown to reverse resistance to CENUs in vitro. | lld:pubmed |
| pubmed-article:1531148 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1531148 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1531148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1531148 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1531148 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:1531148 | pubmed:issn | 0027-8874 | lld:pubmed |
| pubmed-article:1531148 | pubmed:author | pubmed-author:EricksonL CLC | lld:pubmed |
| pubmed-article:1531148 | pubmed:author | pubmed-author:KochDD | lld:pubmed |
| pubmed-article:1531148 | pubmed:author | pubmed-author:FisherR IRI | lld:pubmed |
| pubmed-article:1531148 | pubmed:author | pubmed-author:MicetichK CKC | lld:pubmed |
| pubmed-article:1531148 | pubmed:author | pubmed-author:FutscherBB | lld:pubmed |
| pubmed-article:1531148 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1531148 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:1531148 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:1531148 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1531148 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1531148 | pubmed:pagination | 256-60 | lld:pubmed |
| pubmed-article:1531148 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:meshHeading | pubmed-meshheading:1531148-... | lld:pubmed |
| pubmed-article:1531148 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1531148 | pubmed:articleTitle | Phase I study of streptozocin- and carmustine-sequenced administration in patients with advanced cancer. | lld:pubmed |
| pubmed-article:1531148 | pubmed:affiliation | Section of Hematology-Oncology, Stritch School of Medicine, Loyola University of Chicago, Maywood, Ill. 60153. | lld:pubmed |
| pubmed-article:1531148 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1531148 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:1531148 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1531148 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1531148 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1531148 | lld:pubmed |
